Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Causes and evaluation of chronic dyspnea.

Wahls SA.

Am Fam Physician. 2012 Jul 15;86(2):173-82. Review.

2.

[Dyspnea in airway and pulmonary diseases].

Niedermeyer J.

Internist (Berl). 2015 Aug;56(8):882-9. doi: 10.1007/s00108-015-3692-1. German.

PMID:
26129864
3.

Evaluation of chronic dyspnea.

Karnani NG, Reisfield GM, Wilson GR.

Am Fam Physician. 2005 Apr 15;71(8):1529-37. Review.

4.

Bird fancier's lung: a series of 86 patients.

Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Muñoz X.

Medicine (Baltimore). 2008 Mar;87(2):110-30. doi: 10.1097/MD.0b013e31816d1dda.

5.

Cause and evaluation of chronic dyspnea in a pulmonary disease clinic.

Pratter MR, Curley FJ, Dubois J, Irwin RS.

Arch Intern Med. 1989 Oct;149(10):2277-82.

PMID:
2802893
6.

[Acute dyspnoea in elderly patients].

Ray P, Birolleau S, Riou B.

Rev Mal Respir. 2002 Sep;19(4):491-503. Review. French.

PMID:
12417865
7.

Acute dyspnea in the office.

Zoorob RJ, Campbell JS.

Am Fam Physician. 2003 Nov 1;68(9):1803-10. Review.

8.

Natriuretic peptide testing: a window into the diagnosis and prognosis of heart failure.

Januzzi JL Jr.

Cleve Clin J Med. 2006 Feb;73(2):149-52, 155-7. Review.

PMID:
16478039
9.
10.

Diagnostic evaluation of dyspnea.

Morgan WC, Hodge HL.

Am Fam Physician. 1998 Feb 15;57(4):711-6. Review.

11.

Diagnostics in pulmonary hypertension.

Schannwell CM, Steiner S, Strauer BE.

J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):591-602. Review.

12.

Chronic obstructive pulmonary disease: diagnostic considerations.

Dewar M, Curry RW Jr.

Am Fam Physician. 2006 Feb 15;73(4):669-76.

13.

Unexplained dyspnea.

Gillespie DJ, Staats BA.

Mayo Clin Proc. 1994 Jul;69(7):657-63. Review.

PMID:
8015330
14.

Evaluation of the dyspneic patient in the office.

Sarkar S, Amelung PJ.

Prim Care. 2006 Sep;33(3):643-57. Review.

PMID:
17088153
15.

[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].

Sleszycka J, Woźniak K, Banaszek M, Wiechno W, Domagała-Kulawik J.

Pol Merkur Lekarski. 2009 Aug;27(158):92-6. Polish.

PMID:
19856871
16.

Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.

Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A.

J Am Coll Cardiol. 2002 Jan 16;39(2):202-9.

17.

The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure.

Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KG, Lammers JW, Cowie MR, Grobbee DE, Hoes AW.

Circulation. 2011 Dec 20;124(25):2865-73. doi: 10.1161/CIRCULATIONAHA.111.019216. Epub 2011 Nov 21.

18.

Diagnosis and evaluation of heart failure.

King M, Kingery J, Casey B.

Am Fam Physician. 2012 Jun 15;85(12):1161-8. Review.

19.

Evaluation of exertional dyspnea in the active duty patient: the diagnostic approach and the utility of clinical testing.

Morris MJ, Grbach VX, Deal LE, Boyd SY, Morgan JA, Johnson JE.

Mil Med. 2002 Apr;167(4):281-8.

PMID:
11977877
20.

Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.

Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N.

J Med Assoc Thai. 2003 May;86 Suppl 1:S87-95.

PMID:
12866774

Supplemental Content

Support Center